Prostate Cancer Clinical Trial

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Summary

The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Prostate cancer treated primarily with open, laparoscopic or robotically assisted prostatectomy.
Maximum PSA value of 20 ng/ml.

Exclusion Criteria:

Evidence of distant metastasis (M1).
Prior systemic chemotherapy for any reason.
Previous irradiation to the pelvis that would compromise the ability to deliver the prescribed study treatment.
Active inflammatory bowel disease (Crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum. (Non-active diverticulitis and Crohn's disease not affecting the rectum are allowed).
History of hip replacement.
Prior or concurrent cancer, other than non-melanomatous skin cancer, unless disease free for at least 5 years.
Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

70

Study ID:

NCT00969111

Recruitment Status:

Recruiting

Sponsor:

Proton Collaborative Group

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

University of Florida Proton Therapy Institute
Jacksonville Florida, 32206, United States More Info
Intake Coordinator
Contact
877-686-6009
Randal H Henderson, MD
Principal Investigator
Northwestern Medicine Chicago Proton Center
Warrenville Illinois, 60555, United States More Info
Don Smith, MS, CCRC
Contact
630-933-7820
[email protected]
Stephen Mihalcik, MD
Principal Investigator
Inova Schar Cancer Institute
Fairfax Virginia, 22031, United States More Info
Sangeetha Moturi
Contact
571-472-0343
[email protected]
Kevin Choe, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

70

Study ID:

NCT00969111

Recruitment Status:

Recruiting

Sponsor:


Proton Collaborative Group

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.